US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 1.100
  • +0.080+7.84%
Close Aug 12 16:00 ET
  • 1.100
  • 0.0000.00%
Post 17:54 ET
229.04MMarket Cap-797P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-80.58%27.79M
-73.51%54.42M
-70.82%81M
-70.82%81M
-57.87%132.11M
-54.67%143.1M
-35.37%205.39M
-26.27%277.63M
-26.27%277.63M
-25.94%313.57M
-Cash and cash equivalents
-58.42%27.79M
-30.45%54.42M
-55.00%45.2M
-55.00%45.2M
-40.24%56.51M
-43.22%66.83M
-34.94%78.24M
-43.85%100.44M
-43.85%100.44M
-46.56%94.57M
-Short-term investments
--0
--0
-79.80%35.8M
-79.80%35.8M
-65.48%75.6M
-61.48%76.27M
-35.63%127.15M
-10.36%177.19M
-10.36%177.19M
-11.14%219M
Receivables
-85.24%581K
-91.42%691K
-70.35%1.33M
-70.35%1.33M
-65.32%1.75M
-37.45%3.94M
10.35%8.05M
-29.71%4.47M
-29.71%4.47M
-41.24%5.05M
-Accounts receivable
-78.61%581K
-90.17%691K
-74.90%923K
-74.90%923K
-74.61%1.15M
-54.75%2.72M
1.27%7.03M
-38.83%3.68M
-38.83%3.68M
-43.24%4.52M
-Accrued interest receivable
----
----
-49.24%403K
-49.24%403K
14.89%602K
321.80%1.22M
187.36%1.02M
127.51%794K
127.51%794K
-15.48%524K
Restricted cash
----
--916K
----
----
----
----
----
----
----
----
Other current assets
-6.88%11.71M
-7.61%12.61M
-34.15%12M
-34.15%12M
-23.84%13.72M
-40.43%12.57M
-8.84%13.65M
14.91%18.22M
14.91%18.22M
16.96%18.01M
Total current assets
-74.89%40.08M
-69.78%68.64M
-68.59%94.33M
-68.59%94.33M
-56.16%147.58M
-53.48%159.61M
-33.22%227.09M
-24.69%300.33M
-24.69%300.33M
-24.76%336.62M
Non current assets
Net PPE
-63.45%39.29M
-60.44%42.95M
-57.89%52.87M
-57.89%52.87M
-53.99%55.65M
-12.03%107.49M
-11.37%108.57M
0.66%125.53M
0.66%125.53M
3.33%120.94M
-Gross PPE
-63.45%39.29M
-60.44%42.95M
-35.88%103.91M
-35.88%103.91M
-53.99%55.65M
-12.03%107.49M
-11.37%108.57M
8.24%162.06M
8.24%162.06M
3.33%120.94M
-Accumulated depreciation
----
----
-39.74%-51.05M
-39.74%-51.05M
----
----
----
-45.97%-36.53M
-45.97%-36.53M
----
Goodwill and other intangible assets
----
----
--0
--0
--0
--0
-43.73%51.56M
-5.54%88.28M
-5.54%88.28M
-15.20%80.95M
-Goodwill
----
----
--0
--0
--0
--0
--0
-5.42%37.55M
-5.42%37.55M
-14.85%34.51M
-Other intangible assets
----
----
----
----
----
----
-2.13%51.56M
-5.64%50.73M
-5.64%50.73M
-15.45%46.44M
Investments and advances
----
----
--0
--0
--0
-18.62%39.04M
-56.84%35.61M
-66.15%29.85M
-66.15%29.85M
-61.62%36.7M
Non current accounts receivable
--13.65M
--17.37M
----
----
----
----
----
----
----
----
Other non current assets
----
----
-2.14%18.13M
-2.14%18.13M
-11.90%16.47M
7.52%18.94M
0.71%17.74M
10.13%18.52M
10.13%18.52M
10.85%18.7M
Total non current assets
-68.01%52.94M
-71.74%60.33M
-72.92%70.99M
-72.92%70.99M
-71.97%72.12M
-39.61%165.47M
-32.07%213.48M
-18.87%262.18M
-18.87%262.18M
-20.83%257.29M
Total assets
-71.39%93.01M
-70.73%128.96M
-70.61%165.32M
-70.61%165.32M
-63.01%219.7M
-47.32%325.07M
-32.67%440.57M
-22.08%562.51M
-22.08%562.51M
-23.11%593.91M
Liabilities
Current liabilities
Payables
18.55%17.59M
-22.35%15.47M
-31.93%15.26M
-31.93%15.26M
-11.06%15.46M
13.47%14.84M
78.70%19.92M
129.72%22.42M
129.72%22.42M
117.74%17.38M
-accounts payable
18.55%17.59M
-22.35%15.47M
-31.93%15.26M
-31.93%15.26M
-11.06%15.46M
13.47%14.84M
78.70%19.92M
129.72%22.42M
129.72%22.42M
117.74%17.38M
Current accrued expenses
-16.90%15.76M
20.00%18.47M
59.57%18.97M
59.57%18.97M
1.34%14.23M
33.51%18.96M
9.16%15.4M
57.40%11.89M
57.40%11.89M
-5.20%14.05M
Current debt and capital lease obligation
----
----
11.33%4.59M
11.33%4.59M
----
----
----
2.38%4.12M
2.38%4.12M
----
-Current capital lease obligation
----
----
11.33%4.59M
11.33%4.59M
----
----
----
2.38%4.12M
2.38%4.12M
----
Current deferred liabilities
----
----
--0
--0
-97.93%1.49M
-91.28%6.87M
-88.15%9.58M
-39.59%51.78M
-39.59%51.78M
-20.52%71.89M
Current liabilities
-27.49%39.01M
-30.42%40.24M
-57.27%47.73M
-57.27%47.73M
-60.38%48.48M
-55.17%53.79M
-51.20%57.84M
-12.65%111.71M
-12.65%111.71M
-7.23%122.36M
Non current liabilities
Long term debt and capital lease obligation
-20.00%29.1M
-18.26%30.82M
-14.03%33.52M
-14.03%33.52M
-11.91%34.98M
-12.42%36.37M
-11.94%37.7M
-11.51%38.99M
-11.51%38.99M
9.92%39.71M
-Long term capital lease obligation
-20.00%29.1M
-18.26%30.82M
-14.03%33.52M
-14.03%33.52M
-11.91%34.98M
-12.42%36.37M
-11.94%37.7M
-11.51%38.99M
-11.51%38.99M
9.92%39.71M
Non current deferred liabilities
----
----
--0
--0
--0
--0
-94.79%8.19M
-33.31%115.65M
-33.31%115.65M
-36.36%121.38M
Other non current liabilities
-3.55%1.22M
-1.95%1.21M
-1.66%1.19M
-1.66%1.19M
0.46%1.32M
-1.40%1.27M
-0.57%1.23M
-0.82%1.21M
-0.82%1.21M
-82.81%1.31M
Total non current liabilities
-19.45%30.32M
-32.04%32.02M
-77.73%34.7M
-77.73%34.7M
-77.65%36.29M
-78.96%37.64M
-76.59%47.12M
-28.74%155.84M
-28.74%155.84M
-30.74%162.4M
Total liabilities
-24.18%69.32M
-31.15%72.26M
-69.19%82.43M
-69.19%82.43M
-70.23%84.78M
-69.40%91.43M
-67.18%104.96M
-22.80%267.55M
-22.80%267.55M
-22.28%284.76M
Shareholders'equity
Share capital
17.56%2.08M
18.57%2.04M
6.77%1.78M
6.77%1.78M
9.51%1.77M
15.45%1.77M
17.11%1.72M
14.32%1.67M
14.32%1.67M
11.27%1.62M
-common stock
17.56%2.08M
18.57%2.04M
6.77%1.78M
6.77%1.78M
9.51%1.77M
15.45%1.77M
17.11%1.72M
14.32%1.67M
14.32%1.67M
11.27%1.62M
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-20.10%-1.49B
-29.10%-1.46B
-22.45%-1.41B
-22.45%-1.41B
-22.75%-1.35B
-19.02%-1.24B
-12.71%-1.13B
-20.11%-1.15B
-20.11%-1.15B
-19.35%-1.1B
Paid-in capital
2.66%1.52B
3.33%1.52B
2.88%1.49B
2.88%1.49B
4.41%1.49B
7.75%1.48B
9.46%1.47B
8.70%1.45B
8.70%1.45B
7.49%1.42B
Gains losses not affecting retained earnings
0.89%-5.88M
-0.75%-5.8M
45.32%-4.6M
45.32%-4.6M
65.36%-6.58M
54.89%-5.94M
17.21%-5.76M
-110.79%-8.4M
-110.79%-8.4M
-2,949.44%-19M
Total stockholders'equity
-89.86%23.69M
-83.11%56.7M
-71.90%82.89M
-71.90%82.89M
-56.36%134.92M
-26.59%233.64M
0.33%335.61M
-21.42%294.96M
-21.42%294.96M
-23.86%309.15M
Noncontrolling interests
----
----
--0
--0
----
----
----
--0
--0
----
Total equity
-89.86%23.69M
-83.11%56.7M
-71.90%82.89M
-71.90%82.89M
-56.36%134.92M
-26.59%233.64M
0.33%335.61M
-21.42%294.96M
-21.42%294.96M
-23.86%309.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -80.58%27.79M-73.51%54.42M-70.82%81M-70.82%81M-57.87%132.11M-54.67%143.1M-35.37%205.39M-26.27%277.63M-26.27%277.63M-25.94%313.57M
-Cash and cash equivalents -58.42%27.79M-30.45%54.42M-55.00%45.2M-55.00%45.2M-40.24%56.51M-43.22%66.83M-34.94%78.24M-43.85%100.44M-43.85%100.44M-46.56%94.57M
-Short-term investments --0--0-79.80%35.8M-79.80%35.8M-65.48%75.6M-61.48%76.27M-35.63%127.15M-10.36%177.19M-10.36%177.19M-11.14%219M
Receivables -85.24%581K-91.42%691K-70.35%1.33M-70.35%1.33M-65.32%1.75M-37.45%3.94M10.35%8.05M-29.71%4.47M-29.71%4.47M-41.24%5.05M
-Accounts receivable -78.61%581K-90.17%691K-74.90%923K-74.90%923K-74.61%1.15M-54.75%2.72M1.27%7.03M-38.83%3.68M-38.83%3.68M-43.24%4.52M
-Accrued interest receivable ---------49.24%403K-49.24%403K14.89%602K321.80%1.22M187.36%1.02M127.51%794K127.51%794K-15.48%524K
Restricted cash ------916K--------------------------------
Other current assets -6.88%11.71M-7.61%12.61M-34.15%12M-34.15%12M-23.84%13.72M-40.43%12.57M-8.84%13.65M14.91%18.22M14.91%18.22M16.96%18.01M
Total current assets -74.89%40.08M-69.78%68.64M-68.59%94.33M-68.59%94.33M-56.16%147.58M-53.48%159.61M-33.22%227.09M-24.69%300.33M-24.69%300.33M-24.76%336.62M
Non current assets
Net PPE -63.45%39.29M-60.44%42.95M-57.89%52.87M-57.89%52.87M-53.99%55.65M-12.03%107.49M-11.37%108.57M0.66%125.53M0.66%125.53M3.33%120.94M
-Gross PPE -63.45%39.29M-60.44%42.95M-35.88%103.91M-35.88%103.91M-53.99%55.65M-12.03%107.49M-11.37%108.57M8.24%162.06M8.24%162.06M3.33%120.94M
-Accumulated depreciation ---------39.74%-51.05M-39.74%-51.05M-------------45.97%-36.53M-45.97%-36.53M----
Goodwill and other intangible assets ----------0--0--0--0-43.73%51.56M-5.54%88.28M-5.54%88.28M-15.20%80.95M
-Goodwill ----------0--0--0--0--0-5.42%37.55M-5.42%37.55M-14.85%34.51M
-Other intangible assets -------------------------2.13%51.56M-5.64%50.73M-5.64%50.73M-15.45%46.44M
Investments and advances ----------0--0--0-18.62%39.04M-56.84%35.61M-66.15%29.85M-66.15%29.85M-61.62%36.7M
Non current accounts receivable --13.65M--17.37M--------------------------------
Other non current assets ---------2.14%18.13M-2.14%18.13M-11.90%16.47M7.52%18.94M0.71%17.74M10.13%18.52M10.13%18.52M10.85%18.7M
Total non current assets -68.01%52.94M-71.74%60.33M-72.92%70.99M-72.92%70.99M-71.97%72.12M-39.61%165.47M-32.07%213.48M-18.87%262.18M-18.87%262.18M-20.83%257.29M
Total assets -71.39%93.01M-70.73%128.96M-70.61%165.32M-70.61%165.32M-63.01%219.7M-47.32%325.07M-32.67%440.57M-22.08%562.51M-22.08%562.51M-23.11%593.91M
Liabilities
Current liabilities
Payables 18.55%17.59M-22.35%15.47M-31.93%15.26M-31.93%15.26M-11.06%15.46M13.47%14.84M78.70%19.92M129.72%22.42M129.72%22.42M117.74%17.38M
-accounts payable 18.55%17.59M-22.35%15.47M-31.93%15.26M-31.93%15.26M-11.06%15.46M13.47%14.84M78.70%19.92M129.72%22.42M129.72%22.42M117.74%17.38M
Current accrued expenses -16.90%15.76M20.00%18.47M59.57%18.97M59.57%18.97M1.34%14.23M33.51%18.96M9.16%15.4M57.40%11.89M57.40%11.89M-5.20%14.05M
Current debt and capital lease obligation --------11.33%4.59M11.33%4.59M------------2.38%4.12M2.38%4.12M----
-Current capital lease obligation --------11.33%4.59M11.33%4.59M------------2.38%4.12M2.38%4.12M----
Current deferred liabilities ----------0--0-97.93%1.49M-91.28%6.87M-88.15%9.58M-39.59%51.78M-39.59%51.78M-20.52%71.89M
Current liabilities -27.49%39.01M-30.42%40.24M-57.27%47.73M-57.27%47.73M-60.38%48.48M-55.17%53.79M-51.20%57.84M-12.65%111.71M-12.65%111.71M-7.23%122.36M
Non current liabilities
Long term debt and capital lease obligation -20.00%29.1M-18.26%30.82M-14.03%33.52M-14.03%33.52M-11.91%34.98M-12.42%36.37M-11.94%37.7M-11.51%38.99M-11.51%38.99M9.92%39.71M
-Long term capital lease obligation -20.00%29.1M-18.26%30.82M-14.03%33.52M-14.03%33.52M-11.91%34.98M-12.42%36.37M-11.94%37.7M-11.51%38.99M-11.51%38.99M9.92%39.71M
Non current deferred liabilities ----------0--0--0--0-94.79%8.19M-33.31%115.65M-33.31%115.65M-36.36%121.38M
Other non current liabilities -3.55%1.22M-1.95%1.21M-1.66%1.19M-1.66%1.19M0.46%1.32M-1.40%1.27M-0.57%1.23M-0.82%1.21M-0.82%1.21M-82.81%1.31M
Total non current liabilities -19.45%30.32M-32.04%32.02M-77.73%34.7M-77.73%34.7M-77.65%36.29M-78.96%37.64M-76.59%47.12M-28.74%155.84M-28.74%155.84M-30.74%162.4M
Total liabilities -24.18%69.32M-31.15%72.26M-69.19%82.43M-69.19%82.43M-70.23%84.78M-69.40%91.43M-67.18%104.96M-22.80%267.55M-22.80%267.55M-22.28%284.76M
Shareholders'equity
Share capital 17.56%2.08M18.57%2.04M6.77%1.78M6.77%1.78M9.51%1.77M15.45%1.77M17.11%1.72M14.32%1.67M14.32%1.67M11.27%1.62M
-common stock 17.56%2.08M18.57%2.04M6.77%1.78M6.77%1.78M9.51%1.77M15.45%1.77M17.11%1.72M14.32%1.67M14.32%1.67M11.27%1.62M
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -20.10%-1.49B-29.10%-1.46B-22.45%-1.41B-22.45%-1.41B-22.75%-1.35B-19.02%-1.24B-12.71%-1.13B-20.11%-1.15B-20.11%-1.15B-19.35%-1.1B
Paid-in capital 2.66%1.52B3.33%1.52B2.88%1.49B2.88%1.49B4.41%1.49B7.75%1.48B9.46%1.47B8.70%1.45B8.70%1.45B7.49%1.42B
Gains losses not affecting retained earnings 0.89%-5.88M-0.75%-5.8M45.32%-4.6M45.32%-4.6M65.36%-6.58M54.89%-5.94M17.21%-5.76M-110.79%-8.4M-110.79%-8.4M-2,949.44%-19M
Total stockholders'equity -89.86%23.69M-83.11%56.7M-71.90%82.89M-71.90%82.89M-56.36%134.92M-26.59%233.64M0.33%335.61M-21.42%294.96M-21.42%294.96M-23.86%309.15M
Noncontrolling interests ----------0--0--------------0--0----
Total equity -89.86%23.69M-83.11%56.7M-71.90%82.89M-71.90%82.89M-56.36%134.92M-26.59%233.64M0.33%335.61M-21.42%294.96M-21.42%294.96M-23.86%309.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Gene Editing
Gene Editing
Intraday-0.87%
Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.16%